Zhejiang Huahai Pharmaceutical Co., Ltd.
600521
Rangering i aksjer
#4354
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Aksjekurs
$2.41
Markedsverdi
$3.61B
Endring (1 dag)
-0.60%
Endring (1 år)
-10.36%
Land
CN
Handel Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Kategori
Healthcare
Inntekter for Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Inntekter i Jun 2026 TTM: $116.37M
Ifølge Zhejiang Huahai Pharmaceutical Co., Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat $116.37M. I 2023 hadde selskapet et resultat på $155.44M, en nedgang sammenlignet med resultatet i 2022, som var $218.75M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Zhejiang Huahai Pharmaceutical Co., Ltd. fra 2000 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $116.37M | -41.96% |
| 2024 | $200.52M | 29.00% |
| 2023 | $155.44M | -28.94% |
| 2022 | $218.75M | 76.68% |
| 2021 | $123.81M | -33.45% |
| 2020 | $186.04M | 70.26% |
| 2019 | $109.27M | 378.00% |
| 2018 | $22.86M | -80.91% |
| 2017 | $119.77M | 46.64% |
| 2016 | $81.68M | 1.26% |
| 2015 | $80.66M | 59.65% |
| 2014 | $50.52M | -25.67% |
| 2013 | $67.97M | 5.47% |
| 2012 | $64.44M | 48.73% |
| 2011 | $43.33M | 123.78% |
| 2010 | $19.36M | -32.37% |
| 2009 | $28.63M | 16.51% |
| 2008 | $24.57M | -5.07% |
| 2007 | $25.88M | 35.84% |
| 2006 | $19.05M | -12.70% |
| 2005 | $21.83M | 10.70% |
| 2004 | $19.72M | 36.00% |
| 2003 | $14.50M | 63.58% |
| 2002 | $8.86M | 36.52% |
| 2001 | $6.49M | 2.99% |
| 2000 | $6.30M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 1,416.29% |
IN
|
